ZFP11 inhibitors are a class of chemical compounds that specifically target zinc finger protein 11 (ZFP11), a transcription factor involved in regulating gene expression. Like other zinc finger proteins, ZFP11 contains zinc finger motifs, which are structural domains that enable the protein to bind to particular DNA sequences. These zinc finger motifs are stabilized by zinc ions, which are essential for maintaining the proper three-dimensional structure of the protein. ZFP11's ability to bind to DNA is critical for its role in controlling the transcription of various genes that are involved in different cellular processes. Inhibitors of ZFP11 function by disrupting the protein's interaction with DNA, either by destabilizing the zinc finger motifs or by directly preventing the protein from binding to its target DNA sequences, which leads to changes in gene regulation.
The mechanisms by which ZFP11 inhibitors exert their effects can vary depending on the chemical structure of the compounds. One common approach is to chelate the zinc ions that are necessary for maintaining the integrity of the zinc finger motifs. By binding to these zinc ions, the inhibitors cause the zinc finger motifs to lose their functional conformation, thereby preventing ZFP11 from effectively binding to DNA. This disruption of DNA binding impairs ZFP11's ability to regulate gene expression. Additionally, some inhibitors may act by blocking key protein-protein interactions that are essential for ZFP11 to form transcriptional complexes or interact with other regulatory proteins. By hindering these interactions, the inhibitors further reduce ZFP11's capacity to control gene expression. Research into ZFP11 inhibitors provides valuable insights into the role of zinc finger proteins in transcriptional regulation, offering a deeper understanding of how they influence complex gene networks and cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits transcription by intercalating DNA, preventing RNA polymerase from elongating. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol inhibits ZFP11 expression through its ability to modulate various signaling pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin inhibits ZFP11 by affecting multiple pathways involved in gene expression and protein synthesis. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide inhibits ZFP11 expression by interfering with topoisomerase II, leading to DNA damage and repair. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $57.00 $93.00 $240.00 $713.00 | 8 | |
Ellagic acid may inhibit ZFP11 by modulating transcription factors and impacting gene expression pathways. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $90.00 | 1 | |
Berberine inhibits ZFP11 through its ability to modulate gene expression and interfere with DNA transcription. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits ZFP11 by targeting cyclin-dependent kinases, which are involved in gene transcription. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits ZFP11 expression by trapping topoisomerase I-DNA complexes, leading to DNA damage. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $142.00 $558.00 | 4 | |
Ellipticine inhibits ZFP11 expression by intercalating DNA and affecting the function of DNA topoisomerases. | ||||||